NCT02051439

Brief Summary

This study was designed to compare the party balloon assisted Valsalva with the conventional Valsava for exhibiting the reverse venous flow in superficial venous valvular incompetence duplex examination.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 27, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 31, 2014

Completed
Last Updated

January 31, 2014

Status Verified

January 1, 2014

Enrollment Period

4 months

First QC Date

January 27, 2014

Last Update Submit

January 29, 2014

Conditions

Keywords

Varicose VeinsVenous InsufficiencyDopplerDuplexValsava

Outcome Measures

Primary Outcomes (1)

  • Number of successfully identified reflux with different method of Valsava technic

    Patients performed conventional Valsava for identify venous reflux on duplex scan for 3 times then they performed balloon assisted Valsava for identify venous reflux on duplex scan for 3 times. The Outcome is number of successfully identified reflux with different method of Valsava technic.

    20 minutes

Secondary Outcomes (3)

  • The timing for the instruction of conventional Valsava and balloon assisted Valsava

    20 minutes

  • The timing of identified venous reflux demonstrated in the duplex scan of conventional Valsava and balloon assisted Valsava

    20 minutes

  • The total timing for duplex scan examination in conventional Valsava and balloon assisted Valsava

    20 minutes

Study Arms (1)

Valsava

OTHER

The patients were randomized to 2 groups. The first group performed conventional Valsava before balloon assisted Valsava. The second group performed balloon assisted Valsava before conventional Valsava for venous reflux examination by duplex scan.

Procedure: Valsava

Interventions

ValsavaPROCEDURE

The patients were randomized to 2 groups. The first group performed conventional Valsava 3 times before balloon assisted Valsava 3 times. The second group performed balloon assisted Valsava 3 times before conventional Valsava 3 times for venous reflux examination by duplex scan.

Valsava

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age within 18-80 years old
  • Visible GSV varicose veins
  • Trendelenburg test part 1 - Negative (Perforator vein incompetence) and
  • Trendelenburg test part 2 - Positive (Saphenofemoral junction competence)
  • Consent to participate in the study.

You may not qualify if:

  • \- CVI from Klippel-Trenaunay syndrome, Deep vein thrombosis (DVT), Arteriovenous fistula (AVF)
  • Failure to language communication
  • Previous heart disease (CAD, Myocardial infarction, Stable angina, Unstable angina, Congestive Heart Failure, Valvular heart disease)
  • Previous lung disease (Asthma, Chronic obstructive pulmonary disease, Bronchiectasia)
  • Abnormalities of oral cavity which cannot hold own breath. (Cleft lip, Cleft palate)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Varicose VeinsVenous Insufficiency

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2014

First Posted

January 31, 2014

Study Start

January 1, 2012

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

January 31, 2014

Record last verified: 2014-01